Client Need
Responding more effectively to future public health emergencies will require rapid acquisition of critical medical technologies. To accelerate future acquisitions of Medical Countermeasure (MCM) technologies, an OTA consortium manager sought to understand the landscape of cutting-edge medical technology companies.
Results
In under a month, we provided a validated and ranked list of over 3,400 suppliers, research institutions, non-profits, and venture capital firms. Additionally, we developed an interactive dashboard allowing users to create custom views of the dataset.
Identified the ecosystem of over 3400 suppliers, non-profit organizations, and research institutions across the 4 identified countermeasures.
...read more
Developed a taxonomy for all four countermeasures and provided an overview of each
...read more
Validated over 3200 suppliers and research institutions and identified if they are a part of existing client’s portfolio, along with their government experience.
...read more
Created an online interactive dashboard with multiple data views for further analysis by client
...read more
Approach
PSF analysts utilized our Rapid Market Intelligence workflow along with traditional analysis to:
- Categorize medical technologies and solutions into one or more of each of the four major medical countermeasures
- Identify, match, and validate cutting edge medical technologies by leveraging PSF's SpendMatch™ and SupplierMatch™ algorithms
- Complement AI-workflow with analyst research to uncover additional startups and emerging companies
- Create a custom report and validated dataset, along with an interactive dashboard
How can we help you?
We're ready to help you discover the right companies and ecosystem partners, understand technology/market trends and track risk/commercialization potential of your portfolio of companies/contractors.
